Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28881850.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Oncotarget 2017 ; 8 (32): 53780-90 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Transforming growth factor ?: A potential biomarker and therapeutic target of ventricular remodeling #MMPMID28881850
Ma Y; Zou H; Zhu XX; Pang J; Xu Q; Jin QY; Ding YH; Zhou B; Huang DS
Oncotarget 2017[Aug]; 8 (32): 53780-90 PMID28881850show ga
Transforming growth factor ? (TGF-?) is a multifunctional cytokine that is synthesized by many types of cells and regulates the cell cycle. Increasing evidence has led to TGF-? receiving increased and deserved attention in recent years because it may play a potentially novel and critical role in the development and progression of myocardial fibrosis and the subsequent progress of ventricular remodeling (VR). Numerous studies have highlighted a crucial role of TGF-? in VR and suggest potential therapeutic targets of the TGF-? signaling pathways for VR. Changes in TGF-? activity may elicit anti-VR activity and may serve as a novel therapeutic target for VR therapy. This review we discusses the smad-dependent signaling pathway, such as TGF-?/Smads, TGF-?/Sirtuins, TGF-?/BMP, TGF-?/miRNAs, TGF-?/MAPK, and Smad-independent signaling pathway of TGF-?, such as TGF-?/PI3K/Akt, TGF-?/Rho/ROCK,TGF-?/Wnt/?-catenin in the cardiac fibrosis and subsequent progression of VR. Furthermore, agonists and antagonists of TGF-? as potential therapeutic targets in VR are also described.